![David Matthews](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Dr. David Matthews is Head-Research at Reset Therapeutics, Inc.
Dr. Matthews was previously employed as VP-Drug Discovery & Exploratory Development by Pathway Therapeutics Ltd., VP-Drug Discovery & Exploratory Development by Pathway Therapeutics, Inc., Executive Director-Oncology Discovery by Exelixis, Inc., Group Leader by Metaxen Llc, and Scientist by Arris Pharmaceuticals Corp.
He received his doctorate degree from Imperial College London.
Former positions of David Matthews
| Companies | Position | End |
|---|---|---|
Pathway Therapeutics Ltd.
 Pathway Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Develops drugs for the treatment of cancer | Corporate Officer/Principal | 2012-12-31 |
Pathway Therapeutics, Inc.
 Pathway Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer and inflammatory diseases | Corporate Officer/Principal | 2012-12-31 |
Synchronicity Pharma, Inc.
 Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Discovers, develops and commercializes novel therapeutics | Chief Tech/Sci/R&D Officer | - |
Metaxen LLC
 Metaxen LLC Pharmaceuticals: MajorHealth Technology Provides compound screening assays and compound optimization services | Corporate Officer/Principal | - |
Arris Pharmaceuticals Corp. | Corporate Officer/Principal | - |
Training of David Matthews
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Pathway Therapeutics, Inc.
Pathway Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer and inflammatory diseases | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Metaxen LLC
Metaxen LLC Pharmaceuticals: MajorHealth Technology Provides compound screening assays and compound optimization services | Health Technology |
Arris Pharmaceuticals Corp. | |
Pathway Therapeutics Ltd.
Pathway Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Discovers, develops and commercializes novel therapeutics | Health Technology |
- Stock Market
- Insiders
- David Matthews
